RE:RE:RE:RE:Talking to Proph PBaelissh, "To reiterate, the buyers of the base business' product have found alternatives so that revenue is NEVER coming back and so we wait to see what the contracted minimums are."
He makes something up...
Annual Report: "Ceapro is the only company in the world producing the only commercial natural avenanthramide product which is featured in several of the best-selling global personal care brands."
The Symrise deal was just extended with renewed commitment securing a "strong foundation" for the future that Symrise equally looing forward to making it successful:
“We believe this renewed commitment is an important milestone in our continued collaboration and this agreement further secures a strong foundation for the future. We are equally looking forward to making it successful in creating value.” CZO news release
CZO has said sales lag the first half of last year by one quarter, its a matter of timing, and that the business is solid. The reordering from the major client was expected shortly. The end-user has been in a well publicized spin-out and reorganization. CZO has a record $5.14 million of inventory on standby which at 50% gross margin is over $10 million in potential revenue. Aveeno and Neutrogena haven't gone anywhere.